Quarterly report pursuant to Section 13 or 15(d)

Derivatives and Fair Value Measurements (Tables)

v3.7.0.1
Derivatives and Fair Value Measurements (Tables)
6 Months Ended
Apr. 01, 2017
Fair Value Disclosures [Abstract]  
Outstanding financial instruments
Outstanding instruments as of April 1, 2017, are as follows:
 
Effective Date
 
Notational
Amount
 
Fixed LIBOR Rate
 
Maturity Date
Interest Rate Swap
September 9, 2013
 
$15 million
 
1.6480
%
 
September 11, 2017
Interest Rate Swap
September 19, 2013
 
$15 million
 
1.4490
%
 
September 19, 2017
Financial liabilities measure at fair value on a recurring basis
The following financial liabilities are measured at fair value on a recurring basis (in thousands):
 
Fair Value Measurements Using
Period Ended
Total
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Interest Rate Swaps
 
 
 
 
 
 
 
April 1, 2017
$
(47
)
 

 
$
(47
)
 

October 1, 2016
$
(182
)
 

 
$
(182
)
 

 
 
 
 
 
 
 
 
Cotton Options
 
 
 

 
 
 
 
April 1, 2017
$
(44
)
 
$
(44
)
 

 

October 1, 2016
$

 
$

 

 

 
 
 
 
 
 
 
 
Contingent Consideration
 
 
 
 
 
 
 
April 1, 2017
$
(2,300
)
 

 

 
$
(2,300
)
October 1, 2016
$
(2,500
)
 

 

 
$
(2,500
)
Summary of fair value and presentation in the consolidated balance sheets for derivatives
The following table summarizes the fair value and presentation in the Condensed Consolidated Balance Sheets for derivatives related to our interest swap agreements as of April 1, 2017, and October 1, 2016 (in thousands):
 
April 1,
2017
 
October 1,
2016
Deferred tax assets
18

 
70

Accrued expenses
(47
)
 
(182
)
Accumulated other comprehensive loss
$
(29
)
 
$
(112
)